Home » Newsletters » BioWorld Science

BioWorld Science

April 24, 2007

View Archived Issues

GenPhar's novel dengue virus vaccine active against all virus serotypes

Medicure advances phase III study of MC-1 in third quarter

Sirtex Medical to sponsor FAST trial

DelSite secures antigen for phase I study of GelVac nasal powder influenza vaccine

Series D financing at Metabolex to support pipeline progression

Aranesp study shows no difference in survival in patients with SCLC

ADX-10059 meets primary endpoint in migraine study

Allergy Therapeutics reports promising results of oral allergy vaccine study

Preclinical data reported for new irofulven analogue MGI-4184

Ganymed closes Series C financing

FTC conditionally approves Acavis' acquisition of Abrika

Dual FAK/Pyk2 kinase inhibitor displays promising preclinical profile

Preclinical development of AT-13387, an HSP90 inhibitor, proceeds towards IND filing

Antisoma and Novartis sign global licensing agreement for AS-1404

MKC-1 disrupts microtubules and multiple survival pathways in hematological cancers

CBLB-612 demonstrates efficacy in primate study

DeveloGen and Andromeda Biotech sign term sheet for DiaPep277 purchase

Futura Medical and GSK sign exclusivity agreement on DermaSys technology

AstraZeneca terminates AGI-1067 license and collaboration agreement

SuperGen to sell mitomycin and paclitaxel to Intas

YM-178: a selective beta3-adrenoceptor agonist for the treatment of overactive bladder

Clinical trial analyses reveal efficacy and safety of CERA in patients with renal anemia

Recent Pharmasset patent describes new therapeutic option for HIV infection

New diagnostic agents for schizophrenia reported by Merck

Switch from epoetin alfa to Hematide feasible in dialysis patients

New treatment options for gastrointestinal disorders disclosed in recent patents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...